Back to Results
First PageMeta Content
Medicine / Neurochemistry / Dopamine agonists / Monoamine oxidase inhibitors / Amphetamines / Purdue Pharma / Oxycodone / Mylan / Dextroamphetamine / Euphoriants / Pharmacology / Anorectics


Court Report By Sherri Oslick -- February 12, 2012 About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Purdue Pharma L.P. et al. v. Sandoz Inc. 1:12-cv-00897; filed February 3
Add to Reading List

Document Date: 2013-07-08 12:36:52


Open Document

File Size: 449,39 KB

Share Result on Facebook

City

New York / /

Company

Grunenthal GMBH / The P.F. Laboratories Inc. / Purdue Pharmaceuticals L.P. / Purdue Pharma L.P. / Johnson Matthey Inc. / Shire Development Inc. / Shire LLC / Mylan Inc. / Sandoz Inc. / Mylan Pharmaceuticals Inc. / /

Event

FDA Phase / /

Facility

District Court of New Jersey / University of Texas Systems / /

MedicalCondition

Attention Deficit Hyperactivty Disorder / pain / /

Organization

Board of Regents / District Court of New Jersey / University of Texas Systems / /

Person

Sherri Oslick / /

Product

Oxycodone Hydrochloride / OxyContin / Vyvanse / OxyContin® / Vyvanse® / /

ProvinceOrState

New Jersey / /

URL

www.patentdocs.org / /

SocialTag